Life Sciences Spotlight: Chinese regulatory enforcement action showing no signs of slowing down; and more
Since our last edition, there has been a number of developments in the life sciences sector across the Asia-Pacific region and we are pleased to be able to update you on these recent trends.
It is evident that the focus on compliance in the region will continue for some time unabated and changes to the regulatory landscape are continuous and increasing. Those in the industry who have responsibility for legal and compliance have an ever-increasing burden in this respect. Not only are the goal posts continually shifting but there are many, many more hurdles that need to be cleared. In short, ensuring compliance is getting much more difficult.
In this issue
- Chinese regulatory enforcement action showing no signs of slowing down
- Patent strategies and loyalty discounts
- Data privacy protection in new PRC consumer rights law effective from 15 March 2014
- Enforcing compliance — how to ensure that employees in Australia comply with regulatory codes
- China’s simplified merger review is effective
- Australian New Zealand therapeutic products agency — will we ever get there?
- M&As, manufacturing and distributing medical devices in Japan
Click on the link below to read the rest of the DLA Piper briefing.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from DLA Piper
News from The Lawyer
Briefings from DLA Piper
Health Alert — Julia Clare v Australian Community Pharmacy Authority; Dr Reid v Medical Council of NSW; and more
DLA Piper has released the 22 December 2014 issue of its Health Alert, which focuses on judgments, legislation and reports in the health sector.
The European Court of Justice (CJEU) has handed down a landmark judgment concerning the patentability of stem cells in Europe.
Analysis from The Lawyer
Regulators are ramping up the pressure in the aftermath of recession, leaving firms to compete for compliance and restructuring work
Shearman & Sterling is making its presence felt in the City, squaring up to magic circle firms and looking to muscle in on key relationships. Private equity house Bridgepoint is one outfit that has had its head turned by the US firm.